MEDI0618 clinical trials
Also written MEDI0618.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses MEDI0618 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- MEDI0618
- 3
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test MEDI0618.
Studies
Open first, then newest update. How each study uses MEDI0618 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic MigraineActive, not recruitingPhase 2AbbVieNCT06602479Written as MEDI0618
- Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT05714254Written as MEDI0618
- A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT04198558Written as MEDI0618